Home
/
/
IPO
/
/
accretion pharmaceuticals ltd

Accretion Pharmaceuticals Ltd

Issue
Opens On	Closes On
14-May-25	16-May-25

Money Payable On
Application	Allotment
101.00	0.00

Minimum Application for shares in Nos : 1200 Further Multiples of : 1200

Lead Managers to the Issue
Project Cost (₹.Cr)	27.45	Jawa Capital Services Pvt Ltd
Project Financed through Current Offer (₹.Cr)	29.75
Post Issue Equity Share Capital (₹.Cr)	11.12
Issue Price (₹)	101.00

Projects

Capital expenditure towards purchase of new equipment/machineries, etc

Capital expenditure towards upgradation of existing mfg facility

Repayment/prepayment of certain borrowings availed by our Company;

Funding working capital requirements

Funding working capital requiremnts

General corporate purposes

Promoted By

Harshad Nanubhai Rathod

Vivek Ashok Kumar Patel

Mayur Popatlal Sojitra

Listing At

NSE - SME

Registrar to the Issue

No Data Available

Registered Office: 29 Xcelon Ind Park 1,Vasna Chacharvadi Sanand, Ahmedabad - 382213, Gujarat, India. Phone : +91 97148 82929 Fax:
Email : care@accretionpharma.com
Website :http://www.accretionpharma.com

Initial public offer of upto 29,46,000 equity shares of face value of Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. 101 per equity share for cash, aggregating up to Rs. 29.75 crores (public issue) out of which 1,47,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. 101 per equity share for cash, aggregating Rs. 1.49 crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of 27,98,400 equity shares of face value of Rs. 10 each, at an issue price of Rs. 101 per equity share for cash, aggregating upto Rs. 28.26 crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.50% and 25.17% respectively of the post-issue paid-up equity share capital of our company.